Steroids and Survival in Critically Ill Adult Patients: A Meta-analysis of 135 Randomized Trials.

尚未翻譯 尚未翻譯
类别 Systematic review
期刊Journal of cardiothoracic and vascular anesthesia
Year 2018
Loading references information

OBJECTIVE:

Corticosteroids have important effects on intermediate outcomes in critically ill patients, but their effect on survival is unknown. The objective of this meta-analysis was to analyze the effect on mortality of corticosteroids in critical and perioperative settings.

DESIGN:

A meta-analysis of randomized trials.

SETTING:

PubMed, Embase, BioMed Central, Google Scholar, and the Cochrane Central Register of Controlled Trials were searched to February 1, 2018, for randomized trials comparing corticosteroids with placebo or standard care.

PARTICIPANTS:

Critically ill or surgical adult patients.

INTERVENTIONS:

Corticosteroids compared with placebo or standard care.

MEASUREMENTS AND MAIN RESULTS:

A total of 44,553 patients from 135 studies were included. Overall, mortality in the corticosteroid group and in the control group were similar (16% v 16%; p = 0.9). Subanalyses identified a beneficial effect of corticosteroids on survival in patients with respiratory system diseases (9% v 13%; p < 0.001) and bacterial meningitis (28% v 32%; p= 0.04), and a detrimental effect on survival in patients with traumatic brain injury (22% v 19%; p < 0.001). No differences in mortality were found in patients with cardiac diseases (7% v 6%; p = 0.7), in patients undergoing cardiac surgery (2.8% v 3.2% p = 0.14), and when treatment duration or patient age were considered.

CONCLUSIONS:

This meta-analysis documents the safety of corticosteroids in the overall critically ill population with the notable exception of brain injury patients, a setting where the authors confirmed their detrimental effect on survival. A possible beneficial effect of corticosteroids on survival was found among patients with respiratory diseases and in patients with bacterial meningitis.
Epistemonikos ID: b625020446062fe22a36c956a8c8ef1a408f18bb
First added on: Jun 08, 2018